CHICAGO (November 7, 2023) — The National Rosacea Society (NRS) has awarded funding for one new study, in addition to continuing support for two ongoing studies, as part of its research grants program to increase knowledge and understanding of the potential causes and other key aspects of rosacea that may lead to improvements in its treatment, prevention or potential cure.
CHICAGO (June 21, 2023) — The National Rosacea Society (NRS) today announced that it is launching a Seal of Acceptance program to identify skin care and cosmetic products that may be suitable for people who suffer from rosacea. Companies interested in pursuing the Seal, to be displayed on accepted product packaging, may learn more and request an application online at www.rosacea.org/seal-of-acceptance/ or by contacting the Society at seal@rosacea.org.
CHICAGO (April 1, 2023) – Targeted rosacea therapies can lead to facial skin free of redness and blemishes, but only if these two key elements are also in place: the patient’s commitment to consistent adherence to the treatment plan and the patience to let it work. The National Rosacea Society (NRS) has designated April as Rosacea Awareness Month to educate the public on this conspicuous, life-disruptive facial disorder affecting 16 million Americans, and urge those who may have it to see a dermatologist for diagnosis and therapy tailored to their individual case.
CHICAGO (February 7, 2023) – Advanced therapies designed to target rosacea’s disease processes combined with treatment plans tailored to each individual’s specific case have made it easier than ever for patients to achieve clear skin. But these treatment advances are only beneficial if sufferers have the patience to allow therapies to do their job.
CHICAGO (November 29, 2022) — The National Rosacea Society (NRS) has awarded funding for two new studies in addition to continuing support for two ongoing studies as part of its research grants program to increase knowledge and understanding of the potential causes and other key aspects of rosacea that may lead to improvements in its treatment, prevention or potential cure.
CHICAGO (November 1, 2022) — The National Rosacea Society (NRS) celebrates its 30th anniversary in 2022. The past three decades have seen tremendous progress toward fulfilling our mission of improving the lives of people with rosacea through awareness, education and support of medical research.
“Thanks to the efforts of the NRS, its members and researchers studying on the disease, rosacea is both more recognized and better understood than ever before,” said Andrew Huff, executive director of the NRS.
CHICAGO (Sept. 14, 2022) — Researchers have long observed that microscopic mites that live as scavengers on normal human skin tend to occur in greater numbers on the faces of rosacea patients. It was unknown, however, whether the higher density of these microorganisms, known as Demodex, was a cause or an effect of this widespread disease affecting 16 million Americans.
BARRINGTON, Illinois (August 2, 2022) — The great majority of rosacea patients have experienced persistent facial redness, and most of them report it is the most frequently bothersome sign they face, according to a recent National Rosacea Society (NRS) survey on rosacea redness sponsored by EPI Health. Furthermore, two-thirds reported experiencing flare-ups more than once a week.
CHICAGO (April 1, 2022) — Thanks to the growing number of sophisticated rosacea therapies, the 16 million Americans with this potentially serious facial disorder who commit to partnering with their physicians can now expect to enjoy a clear complexion without the psychological and emotional burden of its unpredictable and embarrassing effects.
BARRINGTON, Illinois (February 8, 2022) — Sophisticated new therapies designed to target rosacea's disease processes combined with treatment plans tailored to patients’ specific cases have made it easier than ever for sufferers to achieve clear skin. The National Rosacea Society (NRS) has designated April as Rosacea Awareness Month to educate the public on the treatments available for this potentially serious disorder, as well as the importance of a key factor in making them effective: the patient’s ongoing commitment to comply with therapy.
BARRINGTON, Illinois (January 25, 2022) — A pair of new studies help establish the relative prevalence of signs and symptoms of the eyes of rosacea patients (ocular rosacea), as well as the importance of medical therapy.
BARRINGTON, Illinois (Nov. 9, 2021) — The National Rosacea Society (NRS) has awarded funding for two new studies in addition to continuing support for two ongoing studies as part of its research grants program to increase knowledge and understanding of the potential causes and other key aspects of rosacea that may lead to improvements in its treatment, prevention or potential cure.
BARRINGTON, Illinois (August 23, 2021) — New recommendations urging dermatologists to place greater emphasis on persistent facial erythema in rosacea were recently published in the Journal of Drugs in Dermatology.1 Titled “Update on Facial Erythema in Rosacea,” the new publication is based on a recent National Rosacea Society (NRS) roundtable to discuss this key aspect of the disorder in light of its recently updated standard classification system and standard management options, new burden-of-illness study results, and significant advances in medical th
BARRINGTON, Illinois (June 15, 2021) — The fact that certain foods can trigger a flare-up in some rosacea patients is well known. In reaction to these foods and other environmental factors such as sun exposure or extreme temperatures, the body releases substances in the skin that cause a chain reaction that leads to flushing, inflammation and, for some, burning and stinging sensations.
BARRINGTON, Illinois (April 22, 2021) — The National Rosacea Society recently conducted a survey focused on how rosacea impacts the social lives of patients. More than 575 people with rosacea took part in the survey, and 85% of the respondents said a flare-up of rosacea frequently or occasionally brings them unwanted attention. Ninety-one percent said this unwanted attention affects how they perceive themselves.
CHICAGO (April 1, 2021) – While protective face masks may both hide and exacerbate the signs and symptoms of rosacea, the 16 million Americans who suffer from this red-face disorder now have access to more treatment options and sophisticated medical care than ever before. The National Rosacea Society (NRS) has designated April as Rosacea Awareness Month to educate the public on this unsightly and potentially serious facial condition, and to urge those who suspect they may have it to see a dermatologist for diagnosis and the most up-to-date therapy.
Barrington, Illinois (March 9, 2021) — The National Rosacea Society today announced it has introduced an updated version of “Understanding Rosacea,” its most popular educational booklet that provides an introduction to this chronic facial skin disorder estimated to affect more than 16 million Americans. The new edition incorporates the updated standard classification and pathophysiology of rosacea, developed by a consensus committee and review panel of 28 rosacea experts worldwide and published in the Journal of the American Academy of Dermatology.
BARRINGTON, Illinois (February 9, 2021) – Although rosacea sufferers now have access to more treatment options and sophisticated care than ever before, many are still untreated or using older therapies that may not be optimally suited for their individual cases.
BARRINGTON, Illinois (January 26, 2021) — Although many of the most commonly prescribed treatments for rosacea are oral or topical antibiotics, a recent survey by the National Rosacea Society (NRS) found the majority of rosacea patients have never heard of antibiotic resistance — the development of harmful bacteria unaffected by antibiotics.
BARRINGTON, Illinois (Nov. 23, 2020) — The National Rosacea Society has awarded funding for two new studies, in addition to continuing support for one ongoing study, as part of its research grants program to increase knowledge and understanding of the potential causes and other key aspects of rosacea that may lead to improvements in its treatment, prevention or potential cure.
